HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qila Sa Selected Research

Sulfadiazine (Sulphadiazine)

2/2015CXCL9 is important for recruiting immune T cells into the brain and inducing an accumulation of the T cells to the areas of tachyzoite proliferation to prevent reactivation of chronic cerebral infection with Toxoplasma gondii.
7/2014VCAM-1/α4β1 integrin interaction is crucial for prompt recruitment of immune T cells into the brain during the early stage of reactivation of chronic infection with Toxoplasma gondii to prevent toxoplasmic encephalitis.
10/2012Toxoplasma gondii antigens recognized by IgG antibodies differ between mice with and without active proliferation of tachyzoites in the brain during the chronic stage of infection.
12/2010Toxoplasma IgG and IgA, but not IgM, antibody titers increase in sera of immunocompetent mice in association with proliferation of tachyzoites in the brain during the chronic stage of infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qila Sa Research Topics

Disease

7Infections
04/2020 - 10/2006
6Cysts
04/2020 - 10/2011
4Persistent Infection
02/2015 - 10/2011
1Kaposi Varicelliform Eruption (Eczema Herpeticum)
01/2022
1Cicatrix (Scar)
01/2022
1Acne Vulgaris
01/2022
1Toxoplasmosis
01/2016
1Encephalitis (Encephalitis, Rasmussen)
07/2014
1Thrombosis (Thrombus)
05/2011

Drug/Important Bio-Agent (IBA)

4Sulfadiazine (Sulphadiazine)FDA Link
02/2015 - 12/2010
3PerforinIBA
04/2020 - 10/2011
2Proteins (Proteins, Gene)FDA Link
01/2017 - 10/2012
2EpitopesIBA
07/2016 - 01/2016
2Immunoglobulin G (IgG)IBA
10/2012 - 12/2010
1Messenger RNA (mRNA)IBA
04/2020
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2018
1Chloroquine (Aralen)FDA LinkGeneric
01/2018
1Pharmaceutical PreparationsIBA
01/2017
1Peptides (Polypeptides)IBA
01/2016
1VaccinesIBA
01/2016
1CXC ChemokinesIBA
02/2015
1Arginine (L-Arginine)FDA Link
02/2015
1Glutamic Acid (Glutamate)FDA Link
02/2015
1Leucine (L-Leucine)FDA Link
02/2015
1IntegrinsIBA
07/2014
1AntibodiesIBA
10/2012
1AntigensIBA
10/2012
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
10/2011
1ChemokinesIBA
10/2011
1CytokinesIBA
10/2011
1Interferon-gamma (Interferon, gamma)IBA
10/2011
1ferric chlorideIBA
05/2011
1elastin microfibril interface located protein (emilin)IBA
05/2011
1Adenosine Diphosphate (ADP)IBA
05/2011
1Immunoglobulin A (IgA)IBA
12/2010
1Immunoglobulin M (IgM)IBA
12/2010
1Alanine (L-Alanine)FDA Link
10/2006

Therapy/Procedure

1Percutaneous Collagen Induction
01/2022
1Therapeutics
01/2022